These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 37541723)
1. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success. Hervás-Corpión I; Alonso MM Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723 [TBL] [Abstract][Full Text] [Related]
2. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas. Stergiopoulos GM; Concilio SC; Galanis E Curr Treat Options Oncol; 2024 Jul; 25(7):952-991. PubMed ID: 38896326 [TBL] [Abstract][Full Text] [Related]
3. Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review. Wang JL; Scheitler KM; Wenger NM; Elder JB Neurosurg Focus; 2021 Feb; 50(2):E2. PubMed ID: 33524943 [TBL] [Abstract][Full Text] [Related]
4. Oncolytic Virotherapy for the Treatment of Malignant Glioma. Foreman PM; Friedman GK; Cassady KA; Markert JM Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902 [TBL] [Abstract][Full Text] [Related]
5. Promises of oncolytic viral therapy for adult and children with brain glioma. Patiño-García A; Alonso MM; Gállego Pérez-Larraya J Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087 [TBL] [Abstract][Full Text] [Related]
6. Clinical advances in oncolytic virotherapy for pediatric brain tumors. Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285 [TBL] [Abstract][Full Text] [Related]
13. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas. Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507 [TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. Shoaf ML; Desjardins A Neurotherapeutics; 2022 Oct; 19(6):1818-1831. PubMed ID: 35674873 [TBL] [Abstract][Full Text] [Related]
15. Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil. Zemp FJ; Corredor JC; Lun X; Muruve DA; Forsyth PA Cytokine Growth Factor Rev; 2010; 21(2-3):103-17. PubMed ID: 20483653 [TBL] [Abstract][Full Text] [Related]
16. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy. Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic virus in gliomas: a review of human clinical investigations. Carpenter AB; Carpenter AM; Aiken R; Hanft S Ann Oncol; 2021 Aug; 32(8):968-982. PubMed ID: 33771666 [TBL] [Abstract][Full Text] [Related]
18. From Bench to Bedside, the Current State of Oncolytic Virotherapy in Pediatric Glioma. Soldozy S; Skaff A; Soldozy K; Sokolowski JD; Norat P; Yagmurlu K; Sharifi KA; Tvrdik P; Park MS; Kalani MYS; Jane JA; Syed HR Neurosurgery; 2020 Nov; 87(6):1091-1097. PubMed ID: 32542365 [TBL] [Abstract][Full Text] [Related]
19. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas. Zeng J; Li X; Sander M; Zhang H; Yan G; Lin Y Front Immunol; 2021; 12():721830. PubMed ID: 34675919 [TBL] [Abstract][Full Text] [Related]